SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-035364
Filing Date
2009-08-14
Accepted
2009-08-14 15:14:34
Documents
5
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b76236rxe10vq.htm 10-Q 184250
2 EX-10.1 AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN RXI PHARMACEUTICALS CORPORATIO b76236rxexv10w1.htm EX-10.1 5777
3 EX-31.1 SARBANES-OXLEY ACT SECTION 302 CERTIFICATION OF TOD WOOLF b76236rxexv31w1.htm EX-31.1 8246
4 EX-31.2 SARBANES-OXLEY ACT SECTION 302 CERTIFICATION OF STEPHEN J. DIPALMA b76236rxexv31w2.htm EX-31.2 8531
5 EX-32.1 SARBANES-OXLEY ACT SECTION 906 CERTIFICATION OF TOD WOOLF AND STEPHEN J. b76236rxexv32w1.htm EX-32.1 4347
  Complete submission text file 0000950123-09-035364.txt   212482
Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861
RXI PHARMACEUTICALS CORP (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 091015161
SIC: 2834 Pharmaceutical Preparations